Danaher Corporation $DHR Stock Purchased by Fulcrum Asset Management LLP

Posted by Geri Gentry on Nov 10th, 2026

Fulcrum Asset Management LLP grew its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 36.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 22,425 shares of the conglomerate’s stock after acquiring an additional 5,966 shares during the quarter. Fulcrum Asset Management LLP’s holdings in Danaher were worth $5,071,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of DHR. BlackRock Inc. bought a new position in Danaher during the second quarter valued at approximately $10,492,520,000. Wellington Management Group LLP boosted its position in shares of Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after acquiring an additional 1,542,310 shares during the last quarter. Jupiter Topco LLC bought a new position in shares of Danaher during the 2nd quarter valued at approximately $1,456,317,000. Generation Investment Management LLP purchased a new position in shares of Danaher in the second quarter valued at $1,287,949,000. Finally, Bank of America Corp DE purchased a new position in shares of Danaher in the second quarter valued at $993,846,000. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

NYSE DHR opened at $235.21 on Tuesday. The company has a market cap of $165.48 billion, a P/E ratio of 38.50, a P/E/G ratio of 2.95 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The business’s 50 day moving average price is $220.65 and its 200-day moving average price is $201.57. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. Danaher’s revenue was up 8.3% on a year-over-year basis. During the same period last year, the company earned $1.89 earnings per share. Sell-side analysts predict that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were paid a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio is currently 26.19%.

Analysts Set New Price Targets

Several brokerages recently weighed in on DHR. Barclays boosted their price target on shares of Danaher from $255.00 to $260.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Stifel Nicolaus lifted their price objective on shares of Danaher from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Thursday, October 22nd. DZ Bank downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 27th. Royal Bank Of Canada upped their target price on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. Finally, Weiss Ratings raised shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Eighteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $242.91.

Check Out Our Latest Analysis on DHR

Insider Buying and Selling at Danaher

In other news, CAO Christopher Bouda sold 7,598 shares of the firm’s stock in a transaction dated Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the sale, the chief accounting officer owned 9,107 shares in the company, valued at approximately $2,136,137.92. This trade represents a 45.48% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 10.80% of the company’s stock.

Danaher Company Profile

(Free Report)

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing.

The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.